Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 3/24/15  and contains information from public web pages and contributions from the ZoomInfo community.

Prof. Michael Mervyn Katz

Wrong Prof. Michael Mervyn Katz?


Phone: +27 *********
Email: m***@***.com
Local Address: South Africa
Company Description: ENSafrica has established offices and a growing footprint throughout Africa. Its offering to clients is unique, in that it is focused on Africa, and its offices do...   more

Employment History

  • Chairman
    ENS (Edward Nathan Sonnenbergs)
  • Chairman
    Corporate Commercial
  • Chairman
    Nedcor Investment Bank Ltd.
  • Chief Executive Officer
    Nedcor Investment Bank Ltd.
  • Non-Executive Director
    Nedcor Investment Bank Ltd.
  • Corporate Lawyer, Tax Adviser To Government, Chairman
    Edward Nathan & Friedland
  • Professor
    Edward Nathan & Friedland
  • Chairman
    Corporate Commercial Department
  • Non-Executive Vice Chairman of Nedbank Group
    Nedbank Group Limited

Board Memberships and Affiliations

  • Board Member
    Nedbank Group Limited


  • Masters Degree , Company Law
65 Total References
Web References
In a speech submitted at the ENF-AfricaBio Breakfast Forum Meeting on Biotechnology, February 15, Prof. Michael Katz stated that "biotechnology's coming of age" was one of the new sweeping trends. According to Fortune Magazine (14 August 2000) biotech ranks alongside communications networking, entertainment and financial services as technologies which have the potential to transform the economy.
Katz, well-known corporate lawyer, tax adviser to Government, Chairman of Edward Nathan Friedland and Chairman of NIB, also quoted the Ernst & Young 2001 report which stated that "biotechnology will become the most dynamic industry, creating a platform for products affecting agriculture, chemicals, pharmaceuticals and affecting computer technology. This is evident from intense expansion of American biotechnology where by June 2000 some 9300 products have been tested in programmes relating to treatment of cancer, contagious diseases, and neurological disorders", says Katz. "Bearing that in mind, it is clear that biotechnology companies are the future winners in the equity market", concludes Katz.
Business Report - Nedcor faces quiz on cost of ENF deal [cached]
It is understood that a deal with Nedcor was first discussed in October 1999 between ENF senior partner Michael Katz and Nedcor's chief executive at the time, Richard Laubscher.
The initial plan involved only Katz moving to Nedcor and picking up a transfer fee of R100 million.
Ironically, Katz was the chairman of the commission that had recommended this change.
Business Day, 30 April 2004 [cached]
"In 1999, Richard Laubscher, the former Nedcor chief executive, through discussions with Michael Katz, became aware that ENF was considering merging with an international legal practice.
"Nedcor/NIB then entered into discussions with ENF to purchase its corporate law advisory business.The chairman of ENF, Professor Michael Katz, although a non-executive director of Nedcor at the time, was not involved in his capacity as a director of Nedcor.Because of Michael Katz's position, great care was taken not to involve him on the Nedcor side when the acquisition of ENF was considered.Michael Katz was involved only as one of the ENF representatives," the statement said.
It continued: "Following initial negotiations between the Nedcor executives and ENF, the proposed transaction to acquire the corporate advisory business of ENF was presented to the Nedcor chairman's committee on 18 October 1999.Six non-executive directors and six of the executive committee members were present and discussed the issue.It was agreed by the committee that the executive management could proceed with the negotiations.
Michael Katz, who was a non-executive director representative on the committee, recused himself from these discussions.
Michael Katz recused himself from the decision.
Nedbank Group | Board of directors, 25 Nov 2009 [cached]
Michael Katz
Prof Michael Mervyn Katz (64) Independent Non-executive Director
Michael Katz is Chairman of Edward Nathan Sonnenbergs Inc. He was Chairman of the Commission of Inquiry into the Tax System of South Africa and Tax Advisory Committee. He is an honorary professor of Company Law at the University of the Witwatersrand. He is also a nonexecutive director of Nampak Limited and a member of the Securities Regulatory Panel.
Nedbank Group - Annual report 2005 : Board of Directors, 1 Jan 2005 [cached]
2 Prof Michael Mervyn Katz (61)
Professor Michael Katz is non-executive Vice-chairman of Nedbank Group, Nedbank Limited and Chairman of Edward Nathan (Proprietary) Limited.He is Chairman of the Tax Advisory Committee, as well as an honorary professor of Company Law at the University of the Witwatersrand.Professor Katz is also a non-executive director of Nampak Limited.
Other People with the name "Katz":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.